sCTLA-4, CD4+CD25+Foxp3+ regulatory T cells in Behçet's disease patients

Küçük Resim

Tarih

2012

Yazarlar




Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Erişim Hakkı

info:eu-repo/semantics/closedAccess

DOI

Özet

[Abstract Not Available]

Açıklama

Anahtar Kelimeler

Behcet Syndrome; Biological Markers; Case-Control Studies; CD4 Lymphocyte Count; CTLA-4 Antigen; Forkhead Transcription Factors; Humans; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Remission Induction; T-Lymphocytes, Regulatory; Treatment Outcome; azathioprine; CD4 antigen; colchicine; cyclosporin A; cytotoxic T lymphocyte antigen 4; interleukin 2 receptor alpha; prednisolone; salazosulfapyridine; transcription factor FOXP3; biological marker; CTLA4 protein, human; cytotoxic T lymphocyte antigen 4; forkhead transcription factor; FOXP3 protein, human; IL2RA protein, human; immunosuppressive agent; interleukin 2 receptor alpha; arthritis; Behcet disease; CD4+ CD25+ FoxP3+ T lymphocyte; CD4+ CD25+ T lymphocyte; cell count; cell function; cell loss; clinical article; controlled study; disease duration; human; letter; priority journal; protein blood level; protein expression; regulatory T lymphocyte; remission; urogenital ulcer; uveitis; blood; case control study; CD4 lymphocyte count; drug effect; immunology; metabolism; treatment outcome

Kaynak

Clinical and Experimental Rheumatology

WoS Q Değeri

Scopus Q Değeri

Q1

Cilt

30

Sayı

SUPPL.72

Künye

Bağlantı

https://hdl.handle.net/11508/43916

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu

Onay

İnceleme

Ekleyen

Referans Veren

Haklar ve lisanslama

info:eu-repo/semantics/closedAccess